Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Open Label Study to Investigate the Mass Balance, Excretion Pathways and Metabolites After a Single Oral Dose of 500 MG, 3.7 MBq, [14C]BTZ-043 in Healthy Male Volunteers

NCT04874948 is registered in ClinicalTrials.gov with Michael Hoelscher as lead sponsor.

NCT NCT04874948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Open Label Study to Investigate the Mass Balance, Excretion Pathways and Metabolites After a Single Oral Dose of 500 MG, 3.7 MBq, [14C]BTZ-043 in Healthy Male Volunteers
Lead sponsor
Michael Hoelscher
Phase
Phase 1
Overall status
Completed
Start date
October 8, 2021
Completion date
November 9, 2021
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections respiratory, lung diseases, mycobacterium infections, tuberculosis, tuberculosis, pulmonary